< Dirk F Moore Ph.D. » EOHSI Directory - EOHSI

Dirk F Moore, Ph.D.

Associate Professor Rutgers University, School of Public HealthEOHSI – Environmental and Population Health Bio-Sciences
Work School of Public Health Room 215 683 Hoes Lane West Piscataway NJ 08854 Work Phone: 732-235-9748 Work Fax: 732-235-5464
Photo of Dirk F Moore Ph.D.

Biographical Info

Recent Publications

  1. Gulhati, P, Schalck, A, Jiang, S, Shang, X, Wu, CJ, Hou, P, Ruiz, SH, Soto, LS, Parra, E, Ying, H et al.. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. 2023;4 (1):62-80. doi: 10.1038/s43018-022-00500-z. PubMed PMID:36585453
  2. Fosko, NK, Gribkova, Y, Krupa, K, Bs, KJ, Moore, D, Chen, C, Potdevin, L, Kumar, S, Eladoumikdachi, F, Kowzun, MJ et al.. The Use of Intraoperative Ultrasound During Breast Conserving Surgery. Clin Breast Cancer. 2023;23 (1):54-59. doi: 10.1016/j.clbc.2022.10.003. PubMed PMID:36319507
  3. Moore, DF, Sleat, DE, Lobel, P. A Method to Estimate the Distribution of Proteins across Multiple Compartments Using Data from Quantitative Proteomics Subcellular Fractionation Experiments. J Proteome Res. 2022;21 (6):1371-1381. doi: 10.1021/acs.jproteome.1c00781. PubMed PMID:35522998
  4. Gazivoda, VP, Kangas-Dick, AW, Greenbaum, AA, Roshal, J, Chen, C, Moore, DF, Langan, RC, Kennedy, TJ, Minerowicz, C, Alexander, HR et al.. Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study. J Surg Res. 2022;277 :131-137. doi: 10.1016/j.jss.2022.04.005. PubMed PMID:35489218
  5. Dansu, DK, Liang, J, Selcen, I, Zheng, H, Moore, DF, Casaccia, P. PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells. Front Cell Neurosci. 2022;16 :820226. doi: 10.3389/fncel.2022.820226. PubMed PMID:35370564 PubMed Central PMC8968030
  6. Deek, MP, Yegya-Raman, N, Daroui, P, Balasubramanian, S, Malhotra, J, Moore, D, Patel, M, Wang, SJ, Aisner, J, Jabbour, SK et al.. Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer. Ann Palliat Med. 2021;10 (7):7205-7213. doi: 10.21037/apm-21-182. PubMed PMID:34263627
  7. Greco, SH, August, DA, Shah, MM, Chen, C, Moore, DF, Masanam, M, Turner, AL, Jabbour, SK, Javidian, P, Grandhi, MS et al.. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database. Surg Open Sci. 2021;3 :22-28. doi: 10.1016/j.sopen.2020.12.001. PubMed PMID:33490937 PubMed Central PMC7807160
  8. Kangas-Dick, AW, Greenbaum, A, Gall, V, Groisberg, R, Mehnert, J, Chen, C, Moore, DF, Berger, AC, Koshenkov, V. Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma. Ann Surg Oncol. 2021;28 (8):4582-4589. doi: 10.1245/s10434-020-09563-7. PubMed PMID:33486642
  9. Krakora, R, Shih, W, Popli, P, Gorshein, E, Salaru, G, Moore, D, Chen, C, David, K, Bannerji, R. Impact of Insurance Status on Survival Outcomes in Adults With Acute Lymphoblastic Leukemia (ALL): A Single-center Experience. Clin Lymphoma Myeloma Leuk. 2020;20 (11):e890-e896. doi: 10.1016/j.clml.2020.06.010. PubMed PMID:32773302
  10. Shah, MM, NeMoyer, RE, Greco, SH, Chen, C, Moore, DF, Grandhi, MS, Langan, RC, Kennedy, TJ, Javidian, P, Jabbour, SK et al.. Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer Database. J Pancreat Cancer. 2020;6 (1):64-72. doi: 10.1089/pancan.2019.0017. PubMed PMID:32766509 PubMed Central PMC7404823
Search PubMed
Categories: Faculty, Environmental and Population Health Biosciences, Epi Members, Member